Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

MAbs

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer.  11:500-515. 2019
  • Antibody-drug conjugate library prepared by scanning insertion of the aldehyde tag into IgG1 constant regions.  10:1182-1189. 2018
  • Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain.  9:438-454. 2017
  • Insertion of scFv into the hinge domain of full-length IgG1 monoclonal antibody results in tetravalent bispecific molecule with robust properties.  9:240-256. 2017
  • Antibody engineering & therapeutics, the annual meeting of the antibody society December 7-10, 2015, San Diego, CA, USA.  8:617-652. 2016
  • Combining phage display with de novo protein sequencing for reverse engineering of monoclonal antibodies.  8:501-512. 2016
  • The INNs and outs of antibody nonproprietary names.  8:1-9. 2016
  • A hingeless Fc fusion system for site-specific cleavage by IdeS.  8:1118-1125. 2016
  • Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.  8:1425-1434. 2016
  • Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity.  8:1498-1511. 2016
  • Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies.  8:1347-1360. 2016
  • Molecular basis for the mechanism of action of an anti-TACE antibody.  8:1598-1605. 2016
  • Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.  7:981-988. 2015
  • The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies.  7:1084-1093. 2015
  • Antibody engineering and therapeutics conference The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.  6:1115-1123. 2014
  • Engineering toward a bacterial "endoplasmic reticulum" for the rapid expression of immunoglobulin proteins.  6:671-678. 2014
  • Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.  6:577-618. 2014
  • The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics.  5:851-859. 2013
  • The structure of dual-variable-domain immunoglobulin molecules alone and bound to antigen.  5:364-372. 2013
  • Monoclonal antibody therapeutics with up to five specificities: Functional enhancement through fusion of target-specific peptides.  5:208-218. 2013
  • Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis.  4:600-613. 2012
  • Targeting malignant B cells with an immunotoxin against ROR1.  4:349-361. 2012
  • Characterization of the basic charge variants of a human IgG1: effect of copper concentration in cell culture media.  3:577-583. 2011
  • Comparability analysis of protein therapeutics by bottom-up LC-MS with stable isotope-tagged reference standards.  3:387-395. 2011
  • Mining human antibody repertoires.  2:365-378. 2010
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1942-0862

Electronic International Standard Serial Number (EISSN)

  • 1942-0870

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support